World News: 13:00 GMT Friday 9th November 2018. [Chembio Diagnostics, Inc. via Globe Newswire via SPi World News]
MEDFORD, N.Y., Nov. 09, 2018 (GLOBE NEWSWIRE) -- Chembio Diagnostics, Inc. (Nasdaq: CEMI), a leader in point-of-care diagnostic tests for infectious diseases, today announced plans to participate in two upcoming investor conferences.
Chembio’s Chief Executive Officer, John Sperzel, will be participating in one-on-one meetings at the Craig-Hallum Alpha Select Conference on Thursday, November 15, 2018.
Chembio’s Chief Financial Officer, Neil Goldman, is scheduled to present at the Canaccord Genuity Medical Technologies & Diagnostics Forum on Thursday, November 15, 2018, at 11:30 am Eastern Time. Interested parties may access a live or recorded webcast of the presentation on the “Investor Relations” section of the company’s website at . Mr. Goldman will also be participating in one-on-one meetings at the conference.
Globe Newswire: 13:00 GMT Friday 9th November 2018
SPi News is published by Sector Publishing Intelligence Ltd.
© Sector Publishing Intelligence Ltd 2018. [Admin Only]
Sector Publishing Intelligence Ltd.
Agriculture House, Acland Road, DORCHESTER, Dorset DT1 1EF United Kingdom
Registered in England and Wales number 0751938.